CHARLES SCHWAB INVESTMENT MANAGEMENT INC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$51,943,320
+15.5%
326,667
+2.7%
0.02%
+15.4%
Q2 2023$44,984,280
-14.4%
318,000
+1.8%
0.01%
-18.8%
Q1 2023$52,571,757
+1.1%
312,258
+1.6%
0.02%
-5.9%
Q4 2022$52,021,852
-5.7%
307,258
+4.2%
0.02%
-15.0%
Q3 2022$55,178,000
+15.6%
294,893
+0.4%
0.02%
+17.6%
Q2 2022$47,724,000
-12.0%
293,863
+2.0%
0.02%
+6.2%
Q1 2022$54,205,000
-27.2%
288,185
+2.5%
0.02%
-27.3%
Q4 2021$74,471,000
-5.9%
281,193
+2.7%
0.02%
-15.4%
Q3 2021$79,118,000
+3.3%
273,772
-28.7%
0.03%
+4.0%
Q2 2021$76,599,000
+5.2%
383,721
+2.5%
0.02%
-7.4%
Q1 2021$72,803,000
-1.6%
374,477
-3.0%
0.03%
-6.9%
Q4 2020$73,974,000
+29.1%
386,021
-0.6%
0.03%
+11.5%
Q3 2020$57,297,000
+23.4%
388,343
+3.4%
0.03%
+13.0%
Q2 2020$46,418,000
+4.3%
375,513
-18.5%
0.02%
-11.5%
Q1 2020$44,496,000
+9.3%
460,905
+4.7%
0.03%
+18.2%
Q4 2019$40,723,000
+22.7%
440,241
+1.8%
0.02%
+10.0%
Q3 2019$33,176,000
+29.4%
432,596
+45.1%
0.02%
+25.0%
Q2 2019$25,632,000
+42.7%
298,213
-1.9%
0.02%
+33.3%
Q1 2019$17,967,000
+27.8%
304,103
+14.0%
0.01%
+9.1%
Q4 2018$14,063,000
+18.5%
266,645
+24.6%
0.01%
+37.5%
Q3 2018$11,870,000
+24.8%
214,019
+5.8%
0.01%
+14.3%
Q2 2018$9,512,000
+38.1%
202,201
+6.2%
0.01%
+40.0%
Q1 2018$6,890,000
-9.6%
190,417
-9.3%
0.01%
-16.7%
Q4 2017$7,619,000
-11.4%
210,000
-6.4%
0.01%
-25.0%
Q3 2017$8,599,000
-3.7%
224,388
+4.1%
0.01%0.0%
Q2 2017$8,929,000
+7.4%
215,450
-8.8%
0.01%0.0%
Q1 2017$8,315,000
-3.2%
236,201
-15.3%
0.01%
-11.1%
Q4 2016$8,593,000
+6.3%
278,812
+4.2%
0.01%
-10.0%
Q3 2016$8,082,000
+68.2%
267,673
+52.4%
0.01%
+66.7%
Q2 2016$4,805,000
+6.0%
175,590
+3.9%
0.01%0.0%
Q1 2016$4,535,000
-2.1%
169,080
+3.3%
0.01%0.0%
Q4 2015$4,630,000
+12.0%
163,654
+10.3%
0.01%0.0%
Q3 2015$4,133,000
+14.9%
148,394
+70.3%
0.01%
+20.0%
Q2 2015$3,597,000
-52.2%
87,154
-64.9%
0.01%
-54.5%
Q1 2015$7,530,000
+17.2%
247,998
-23.5%
0.01%
+10.0%
Q4 2014$6,423,000
-1.8%
324,351
-1.3%
0.01%
-9.1%
Q3 2014$6,544,000
+35.7%
328,649
+55.4%
0.01%
+37.5%
Q2 2014$4,821,000
+102.2%
211,540
+14.1%
0.01%
+100.0%
Q1 2014$2,384,000
+103.4%
185,380
+115.8%
0.00%
+100.0%
Q4 2013$1,172,000
+20.3%
85,9000.0%0.00%0.0%
Q3 2013$974,000
+34.9%
85,9000.0%0.00%0.0%
Q2 2013$722,00085,9000.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders